Video Results from
Published in : 2014-02-18 | by Bloomberg
Feb. 18 (Bloomberg) -- Bloomberg News' Cristina Alesci reports on the $25 billion deal for Forest labs by Actavis to increase its focus on branded medicine on ...
Published in : 2013-07-03 | by Tribe Pictures
This brand film was produced for the day one launch of the merged Watson Pharmaceutical + Actavis global enterprise creating the 3rd largest generic drug ...
Published in : 2013-01-24 | by New York Stock Exchange
Executives and guests of Watson Pharmaceuticals, Inc., will visit the New York Stock Exchange to celebrate its new global name — Actavis — and a multi-year ...
Published in : 2017-01-02 | by Carolyn's RV Life
As a full time RVer, medical insurance and prescription management can be challenging. Recently I ran out of my migraine medicine so took a trip to Mexico to ...
Published in : 2015-02-16 | by Why Invest In
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ...
Published in : 2013-06-18 | by TheStreet: Investing Strategies
Chase Growth Fund portfolio manager Edward Painvin names his favorite stocks including Visa, Actavis, Thermo Fisher and Precision Castparts.
Published in : 2015-03-04 | by S&P Global Ratings
In this CreditMatters TV segment, Standard & Poor's Director, David Peknay discusses the recent rating actions that were taken on the pending debt transactions ...
Published in : 2013-12-06 | by Freeborn & Peters LLP
Jeffery Cross and Jacob Koering, Partners at Freeborn & Peters LLP present, "After FTC v Actavis, Now What," an ALM Webinar.
Published in : 2013-11-08 | by conradpasa
Created by Amil Toprak.
Published in : 2014-11-17 | by Bill George
Discussion on Bloomberg regarding Actavis plan to buy Allergan.